Free Trial

Anpario (LON:ANP) Share Price Passes Below 200-Day Moving Average - What's Next?

Anpario logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell below their 200‑day moving average: ANP traded as low as GBX 451.34 and last at GBX 456.88, beneath the 200‑day MA of GBX 495.64 on a volume of 67,434 shares.
  • Analysts see upside amid solid fundamentals: Canaccord upgraded ANP to a "buy" and raised its target to GBX 570 (consensus target GBX 570), while the company shows a P/E of 12.12, market cap ~£77.95M, strong liquidity (current ratio 4.32, quick ratio 5.16) and low leverage (debt/equity 0.22).
  • MarketBeat previews the top five stocks to own by June 1st.

Shares of Anpario plc (LON:ANP - Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 495.64 and traded as low as GBX 451.34. Anpario shares last traded at GBX 456.88, with a volume of 67,434 shares changing hands.

Analysts Set New Price Targets

A number of research firms have issued reports on ANP. Canaccord Genuity Group raised Anpario to a "buy" rating and increased their price target for the company from GBX 457 to GBX 570 in a research report on Thursday, April 2nd. Shore Capital Group reaffirmed a "house stock" rating on shares of Anpario in a research report on Monday, January 19th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus price target of GBX 570.

View Our Latest Stock Analysis on Anpario

Anpario Price Performance

The company has a debt-to-equity ratio of 0.22, a quick ratio of 5.16 and a current ratio of 4.32. The company has a market cap of £77.95 million, a price-to-earnings ratio of 12.12 and a beta of 0.92. The business has a 50-day simple moving average of GBX 501.80 and a 200-day simple moving average of GBX 495.64.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines